Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
0.5965
-0.0173 (-2.82%)
At close: Jul 18, 2025, 4:00 PM
0.6250
+0.0285 (4.78%)
After-hours: Jul 18, 2025, 6:53 PM EDT
Veru Inc. Employees
Veru Inc. had 210 employees as of September 30, 2024. The number of employees increased by 21 or 11.11% compared to the previous year.
Employees
210
Change (1Y)
21
Growth (1Y)
11.11%
Revenue / Employee
$80,412
Profits / Employee
-$173,078
Market Cap
87.44M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
VERU News
- 5 weeks ago - Veru to Participate in the Virtual BTIG Obesity Health Forum - GlobeNewsWire
- 7 weeks ago - Veru's Enobosarm Shows Muscle In Wegovy Combo Trial - Benzinga
- 7 weeks ago - Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone - GlobeNewsWire
- 7 weeks ago - Veru: Saving Muscle Mass Amidst The GLP-1 Drug Boom - Seeking Alpha
- 2 months ago - Veru Inc. (VERU) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s (NASDAQ:VERU) Enobosarm Taking GLP-1 Weight Loss to Next Level - Accesswire
- 2 months ago - Veru Participates in a Virtual Investor KOL Connect Segment - GlobeNewsWire
- 2 months ago - Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress - GlobeNewsWire